APA (7th ed.) Citation

Kotikalapudi, N., Sampath, S. J. P., Sukesh Narayan, S., R., B., Nemani, H., Mungamuri, S. K., & Venkatesan, V. (2021). The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: Lessons from in vivo and in vitro model systems. Scientific reports, 11(1), 16983-18. https://doi.org/10.1038/s41598-021-96121-0

Chicago Style (17th ed.) Citation

Kotikalapudi, Nagasuryaprasad, Samuel Joshua Pragasam Sampath, Sinha Sukesh Narayan, Bhonde R., Harishankar Nemani, Sathish Kumar Mungamuri, and Vijayalakshmi Venkatesan. "The Promise(s) of Mesenchymal Stem Cell Therapy in Averting Preclinical Diabetes: Lessons from in Vivo and in Vitro Model Systems." Scientific Reports 11, no. 1 (2021): 16983-18. https://doi.org/10.1038/s41598-021-96121-0.

MLA (9th ed.) Citation

Kotikalapudi, Nagasuryaprasad, et al. "The Promise(s) of Mesenchymal Stem Cell Therapy in Averting Preclinical Diabetes: Lessons from in Vivo and in Vitro Model Systems." Scientific Reports, vol. 11, no. 1, 2021, pp. 16983-18, https://doi.org/10.1038/s41598-021-96121-0.